ACC International Holdings Ltd., Insider at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 150,000 shares at $0.35 ($53K) on 2014-06-13, disclosed to the SEC on 2014-06-16.
Open-market purchase of $52k BCLI by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BCLI | BUY | 2015-10-01 | $22K | — | Filing → |
| BCLI | BUY | 2014-10-15 | $35K | — | Filing → |
| BCLI | BUY | 2014-10-01 | $28K | — | Filing → |